Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03232268
PHASE1
HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies
Sponsor: Institut Paoli-Calmettes
View on ClinicalTrials.gov
Summary
This study aims at evaluating the safety of an approach based on HLA-mismatched Microtransplantation without immunosuppressive treatment in patients With myeloid hemopathies who are ineligible to conventional allograft
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2018-03-09
Completion Date
2026-01-07
Last Updated
2026-10-14
Healthy Volunteers
No
Interventions
BIOLOGICAL
HLA-mismatched microtransplantation
3 administrations of hematopoietic stem cells without immunosupression
Locations (1)
Institut Paoli Calmettes
Marseille, Bouches du Rhône, France